1. Home
  2. HLLY vs VOR Comparison

HLLY vs VOR Comparison

Compare HLLY & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Holley Inc.

HLLY

Holley Inc.

HOLD

Current Price

$3.17

Market Cap

358.2M

ML Signal

HOLD

Logo Vor Biopharma Inc.

VOR

Vor Biopharma Inc.

HOLD

Current Price

$13.76

Market Cap

562.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HLLY
VOR
Founded
1903
2015
Country
United States
United States
Employees
1520
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
358.2M
562.6M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
HLLY
VOR
Price
$3.17
$13.76
Analyst Decision
Strong Buy
Buy
Analyst Count
7
10
Target Price
$4.57
$64.78
AVG Volume (30 Days)
885.2K
576.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
2.86
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$4.95
N/A
Revenue Next Year
$5.75
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.60
$0.13
52 Week High
$4.48
$49.95

Technical Indicators

Market Signals
Indicator
HLLY
VOR
Relative Strength Index (RSI) 33.14 45.51
Support Level $2.73 $11.27
Resistance Level $4.28 $14.73
Average True Range (ATR) 0.23 1.13
MACD -0.09 -0.20
Stochastic Oscillator 15.34 16.12

Price Performance

Historical Comparison
HLLY
VOR

About HLLY Holley Inc.

Holley Inc is a designer, marketer, and manufacturer of high-performance automotive aftermarket products, featuring a portfolio of iconic brands serving the car and truck industry. It offers a diversified line of performance automotive products including fuel injection systems, tuners, exhaust products, carburetors, safety equipment and various other performance automotive products. The Company's products are designed to enhance street, off-road, recreational and competitive vehicle performance through increased horsepower, torque and drivability. The company's brands include Holley, APR, MSD and Flowmaster, among others. It derives revenue from the U.S. and Italy, of which prime revenue is derived from the U.S.

About VOR Vor Biopharma Inc.

Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.

Share on Social Networks: